Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(1.93)
# 2,980
Out of 4,843 analysts
375
Total ratings
32.35%
Success rate
-8.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QURE uniQure | Reiterates: Buy | $70 | $14.47 | +383.76% | 15 | May 29, 2025 | |
| IVVD Invivyd | Maintains: Buy | $10 → $5 | $0.94 | +434.76% | 18 | May 28, 2025 | |
| ONCY Oncolytics Biotech | Reiterates: Buy | $5 | $0.34 | +1,370.59% | 18 | May 21, 2025 | |
| DTIL Precision BioSciences | Reiterates: Buy | $60 | $4.82 | +1,144.81% | 18 | May 21, 2025 | |
| ATAI Atai Life Sciences | Reiterates: Buy | $10 | $2.31 | +332.90% | 19 | May 20, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Reiterates: Buy | $80 | $16.07 | +397.82% | 23 | May 20, 2025 | |
| CMPS COMPASS Pathways | Reiterates: Buy | $45 | $4.16 | +981.73% | 15 | May 12, 2025 | |
| GHRS GH Research | Reiterates: Buy | $40 | $12.04 | +232.23% | 15 | May 9, 2025 | |
| VYGR Voyager Therapeutics | Reiterates: Buy | $30 | $2.74 | +994.89% | 10 | Apr 8, 2025 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $70 | $34.50 | +102.90% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.58 | +287.60% | 1 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.47 | +2,050.54% | 25 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $15.83 | +405.37% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $5.43 | +120.99% | 17 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $304.56 | +64.17% | 26 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.62 | +517.28% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.11 | +800.90% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $36.50 | +173.97% | 20 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $7.26 | +657.58% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $5.84 | +1,184.25% | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $4.94 | +2,126.72% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $25.95 | +227.55% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $7.96 | +1,784.42% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $15.26 | +345.61% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $297.49 | +14.29% | 1 | Aug 18, 2021 |
uniQure
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $14.47
Upside: +383.76%
Invivyd
May 28, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $0.94
Upside: +434.76%
Oncolytics Biotech
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.34
Upside: +1,370.59%
Precision BioSciences
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $4.82
Upside: +1,144.81%
Atai Life Sciences
May 20, 2025
Reiterates: Buy
Price Target: $10
Current: $2.31
Upside: +332.90%
Arrowhead Pharmaceuticals
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $16.07
Upside: +397.82%
COMPASS Pathways
May 12, 2025
Reiterates: Buy
Price Target: $45
Current: $4.16
Upside: +981.73%
GH Research
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $12.04
Upside: +232.23%
Voyager Therapeutics
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $2.74
Upside: +994.89%
Harmony Biosciences Holdings
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $34.50
Upside: +102.90%
Apr 7, 2025
Initiates: Buy
Price Target: $10
Current: $2.58
Upside: +287.60%
Apr 7, 2025
Reiterates: Buy
Price Target: $10
Current: $0.47
Upside: +2,050.54%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $15.83
Upside: +405.37%
Apr 3, 2025
Reiterates: Buy
Price Target: $12
Current: $5.43
Upside: +120.99%
Apr 2, 2025
Reiterates: Buy
Price Target: $500
Current: $304.56
Upside: +64.17%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.62
Upside: +517.28%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $1.11
Upside: +800.90%
Mar 12, 2025
Reiterates: Buy
Price Target: $100
Current: $36.50
Upside: +173.97%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $7.26
Upside: +657.58%
Mar 7, 2025
Reiterates: Buy
Price Target: $75
Current: $5.84
Upside: +1,184.25%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $4.94
Upside: +2,126.72%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $25.95
Upside: +227.55%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $7.96
Upside: +1,784.42%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $15.26
Upside: +345.61%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $297.49
Upside: +14.29%